Skip to main content
. Author manuscript; available in PMC: 2020 Dec 9.
Published in final edited form as: SLAS Discov. 2019 Jan 25;24(3):386–397. doi: 10.1177/2472555218820809

Figure 7.

Figure 7.

(A) CRCs of raw data (RLU) studying the effects of Disulfiram (DSF), its metabolite Diethyldithiocarbamate (DDC) and copper (Cu) gluconate on PANC-1 in both 2D and 3D formats. (B) CRCs for the 5 reference cancer drug control compounds (oxaliplatin, doxorubicin, gemcitabine, 5-fluorouracil and SN-38) versus PANC1 cells in 2D and 3D formats in 384 well. (C). The 3D spheroid formation of the pancreatic cancer cells after 96hrs of drug treatment.